NeoImmuneTech Inc
950220
Company Profile
Business description
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.
Contact
2400 Research Boulevard
Suite 250
RockvilleMD20850
USAT: +1 240 801-9065
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
82
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.50 | 22.70 | 0.26% |
| CAC 40 | 7,779.72 | 8.38 | -0.11% |
| DAX 40 | 23,933.23 | 104.96 | -0.44% |
| Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
| FTSE 100 | 8,716.45 | 9.56 | -0.11% |
| HKSE | 23,207.37 | 366.01 | -1.55% |
| NASDAQ | 19,175.87 | 74.93 | 0.39% |
| Nikkei 225 | 38,099.69 | 333.29 | -0.87% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,912.17 | 23.62 | 0.40% |
| S&P/ASX 200 | 8,435.70 | 25.90 | 0.31% |
| SSE Composite Index | 3,353.10 | 10.34 | -0.31% |